Who owns the GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING trademark?

The GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING trademark is owned by Oncocyte Corporation.

What class is the GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING trademark registered in?

The GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING?

The USPTO serial number for GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING is 98211364.

What is the registration number for GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING?

GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING is registered under USPTO registration number 0.

GRA

USPTO Trademark Record

ABANDONED

GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING

SN 98211364·Reg 0·Filed Oct 05, 2023

Owner Oncocyte Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING (Serial No. 98211364), Registration No. 0, is a abandoned US trademark filed on Oct 05, 2023 by Oncocyte Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING (Reg. #0) is an abandoned US trademark that was filed in 2023 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 05, 2023

SERIAL

98211364

REG#

Owner

Applicant

Oncocyte Corporation

Entity

Corporation

State

Address

15 Cushing, Irvine, CA, 92618

Country

Attorney

NameChristopher D. Olszyk, Jr.

Law firm

Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP

Docket

189898.00053

Address

212 Carnegie Center, Suite 400, Princeton, NJ 08540, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateOct 05, 2023

Serial Number98211364

Registration No.0

Status DateSep 15, 2025

Published for OppositionJun 18, 2024

Mark TypeDesign with words

Attorney Docket189898.00053

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

ABANDONMENT - NO USE STATEMENT FILED

Sep 15, 2025

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Sep 15, 2025

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

SOU EXTENSION 1 FILED

Feb 13, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Feb 13, 2025

SOU EXTENSION 1 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 13, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 12, 2025

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 13, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 18, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 18, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 29, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

May 09, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 09, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 08, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 08, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Apr 05, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 05, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 05, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 29, 2024

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Oct 17, 2023

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 14, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 09, 2023

NEW APPLICATION ENTERED

GRAFT ASSURE DD-CFDNA TRANSPLANT MONITORING

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Oncocyte Corporation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Christopher D. Olszyk, Jr.

Resources

Company